tetano
Editor, Senior Moderator
J Virol
. 2022 Aug 18;e0074122.
doi: 10.1128/jvi.00741-22. Online ahead of print.
UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b
Yuzheng Zhou[SUP] 1 [/SUP], Rong Zheng[SUP] 1 [/SUP], Donglan Liu[SUP] 2 [/SUP], Sixu Liu[SUP] 1 [/SUP], Cyrollah Disoma[SUP] 1 [/SUP], Shiqin Li[SUP] 1 [/SUP], Yujie Liao[SUP] 1 [/SUP], Zongpeng Chen[SUP] 1 [/SUP], Ashuai Du[SUP] 1 [/SUP], Zijun Dong[SUP] 3 [/SUP], Yongxing Zhang[SUP] 1 [/SUP], Pinjia Liu[SUP] 1 [/SUP], Aroona Razzaq[SUP] 1 [/SUP], Dingbin Chen[SUP] 2 [/SUP], Xuan Chen[SUP] 4 [/SUP], Xiankezi Zhong[SUP] 1 [/SUP], Sijie Liu[SUP] 1 [/SUP], Siyi Tao[SUP] 1 [/SUP], Yuxin Liu[SUP] 1 [/SUP], Lunan Xu[SUP] 1 [/SUP], Xu Deng[SUP] 4 [/SUP], Jiada Li[SUP] 5 6 7 8 [/SUP], Taijiao Jiang[SUP] 9 [/SUP], Jincun Zhao[SUP] 2 10 [/SUP], Shanni Li[SUP] 1 [/SUP], Zanxian Xia[SUP] 1 6 7 8 [/SUP]
Affiliations
Abstract
Within the past 2 decades, three highly pathogenic human coronaviruses have emerged, namely, severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The health threats and economic burden posed by these tremendously severe coronaviruses have paved the way for research on their etiology, pathogenesis, and treatment. Compared to SARS-CoV and SARS-CoV-2, MERS-CoV genome encoded fewer accessory proteins, among which the ORF4b protein had anti-immunity ability in both the cytoplasm and nucleus. Our work for the first time revealed that ORF4b protein was unstable in the host cells and could be degraded by the ubiquitin proteasome system. After extensive screenings, it was found that UBR5 (ubiquitin protein ligase E3 component N-recognin 5), a member of the HECT E3 ubiquitin ligases, specifically regulated the ubiquitination and degradation of ORF4b. Similar to ORF4b, UBR5 can also translocate into the nucleus through its nuclear localization signal, enabling it to regulate ORF4b stability in both the cytoplasm and nucleus. Through further experiments, lysine 36 was identified as the ubiquitination site on the ORF4b protein, and this residue was highly conserved in various MERS-CoV strains isolated from different regions. When UBR5 was knocked down, the ability of ORF4b to suppress innate immunity was enhanced and MERS-CoV replication was stronger. As an anti-MERS-CoV host protein, UBR5 targets and degrades ORF4b protein through the ubiquitin proteasome system, thereby attenuating the anti-immunity ability of ORF4b and ultimately inhibiting MERS-CoV immune escape, which is a novel antagonistic mechanism of the host against MERS-CoV infection. IMPORTANCE ORF4b was an accessory protein unique to MERS-CoV and was not present in SARS-CoV and SARS-CoV-2 which can also cause severe respiratory disease. Moreover, ORF4b inhibited the production of antiviral cytokines in both the cytoplasm and the nucleus, which was likely to be associated with the high lethality of MERS-CoV. However, whether the host proteins regulate the function of ORF4b is unknown. Our study first determined that UBR5, a host E3 ligase, was a potential host anti-MERS-CoV protein that could reduce the protein level of ORF4b and diminish its anti-immunity ability by inducing ubiquitination and degradation. Based on the discovery of ORF4b-UBR5, a critical molecular target, further increasing the degradation of ORF4b caused by UBR5 could provide a new strategy for the clinical development of drugs for MERS-CoV.
Keywords: IRF3; MERS-CoV; accessory protein; antiviral mechanism; coronavirus; posttranslational modification.
. 2022 Aug 18;e0074122.
doi: 10.1128/jvi.00741-22. Online ahead of print.
UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b
Yuzheng Zhou[SUP] 1 [/SUP], Rong Zheng[SUP] 1 [/SUP], Donglan Liu[SUP] 2 [/SUP], Sixu Liu[SUP] 1 [/SUP], Cyrollah Disoma[SUP] 1 [/SUP], Shiqin Li[SUP] 1 [/SUP], Yujie Liao[SUP] 1 [/SUP], Zongpeng Chen[SUP] 1 [/SUP], Ashuai Du[SUP] 1 [/SUP], Zijun Dong[SUP] 3 [/SUP], Yongxing Zhang[SUP] 1 [/SUP], Pinjia Liu[SUP] 1 [/SUP], Aroona Razzaq[SUP] 1 [/SUP], Dingbin Chen[SUP] 2 [/SUP], Xuan Chen[SUP] 4 [/SUP], Xiankezi Zhong[SUP] 1 [/SUP], Sijie Liu[SUP] 1 [/SUP], Siyi Tao[SUP] 1 [/SUP], Yuxin Liu[SUP] 1 [/SUP], Lunan Xu[SUP] 1 [/SUP], Xu Deng[SUP] 4 [/SUP], Jiada Li[SUP] 5 6 7 8 [/SUP], Taijiao Jiang[SUP] 9 [/SUP], Jincun Zhao[SUP] 2 10 [/SUP], Shanni Li[SUP] 1 [/SUP], Zanxian Xia[SUP] 1 6 7 8 [/SUP]
Affiliations
- PMID: 35980206
- DOI: 10.1128/jvi.00741-22
Abstract
Within the past 2 decades, three highly pathogenic human coronaviruses have emerged, namely, severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The health threats and economic burden posed by these tremendously severe coronaviruses have paved the way for research on their etiology, pathogenesis, and treatment. Compared to SARS-CoV and SARS-CoV-2, MERS-CoV genome encoded fewer accessory proteins, among which the ORF4b protein had anti-immunity ability in both the cytoplasm and nucleus. Our work for the first time revealed that ORF4b protein was unstable in the host cells and could be degraded by the ubiquitin proteasome system. After extensive screenings, it was found that UBR5 (ubiquitin protein ligase E3 component N-recognin 5), a member of the HECT E3 ubiquitin ligases, specifically regulated the ubiquitination and degradation of ORF4b. Similar to ORF4b, UBR5 can also translocate into the nucleus through its nuclear localization signal, enabling it to regulate ORF4b stability in both the cytoplasm and nucleus. Through further experiments, lysine 36 was identified as the ubiquitination site on the ORF4b protein, and this residue was highly conserved in various MERS-CoV strains isolated from different regions. When UBR5 was knocked down, the ability of ORF4b to suppress innate immunity was enhanced and MERS-CoV replication was stronger. As an anti-MERS-CoV host protein, UBR5 targets and degrades ORF4b protein through the ubiquitin proteasome system, thereby attenuating the anti-immunity ability of ORF4b and ultimately inhibiting MERS-CoV immune escape, which is a novel antagonistic mechanism of the host against MERS-CoV infection. IMPORTANCE ORF4b was an accessory protein unique to MERS-CoV and was not present in SARS-CoV and SARS-CoV-2 which can also cause severe respiratory disease. Moreover, ORF4b inhibited the production of antiviral cytokines in both the cytoplasm and the nucleus, which was likely to be associated with the high lethality of MERS-CoV. However, whether the host proteins regulate the function of ORF4b is unknown. Our study first determined that UBR5, a host E3 ligase, was a potential host anti-MERS-CoV protein that could reduce the protein level of ORF4b and diminish its anti-immunity ability by inducing ubiquitination and degradation. Based on the discovery of ORF4b-UBR5, a critical molecular target, further increasing the degradation of ORF4b caused by UBR5 could provide a new strategy for the clinical development of drugs for MERS-CoV.
Keywords: IRF3; MERS-CoV; accessory protein; antiviral mechanism; coronavirus; posttranslational modification.